Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compliance and acceptance problems with standardized extracts

S B Lehrer1

  • 1Tulane University, Dept. of Medicine, New Orleans, Louisana 70112.

Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fish Allergy: Is It a Real Problem with Surimi-Based Products?

International archives of allergy and immunology·2021
Same author

Shellfish allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Do shrimp-allergic individuals tolerate shrimp-derived glucosamine?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2006
Same author

Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2006
Same author

Risks of allergic reactions to biotech proteins in foods: perception and reality.

Allergy·2005
Same author

Environmental exposure characterization of fish processing workers.

The Annals of occupational hygiene·2005
Same journal

Quality and clinical efficacy of allergen mixtures.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

A bright future for sublingual immunotherapy--contra.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

A bright future for sublingual immunotherapy?--pro.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Prospects for CpG based immunotherapy in asthma and allergy.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Understanding the immunological basis of asthma; immunotherapy and regulatory T cells.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
See all related articles

Allergen standardization requires careful consideration of regulators, manufacturers, allergists, and patients. Addressing uniform units, cost, and commitment is crucial for widespread acceptance of standardized allergen extracts.

Area of Science:

  • Allergy and immunology
  • Biotechnology
  • Regulatory science

Background:

  • Allergen standardization impacts various stakeholders in the allergy community.
  • Current practices face challenges in compliance and acceptance.

Purpose of the Study:

  • To highlight key issues affecting allergen standardization.
  • To propose solutions for maximizing compliance and acceptance of new allergen products.

Main Methods:

  • The study discusses the perspectives of regulators, manufacturers, allergists, and patients.
  • It analyzes challenges related to units, cost, and commitment.

Main Results:

  • Discrepancies in units and global variations pose significant challenges.

Related Experiment Videos

  • The cost of standardization and implementation needs careful management.
  • Continued support for allergen characterization and standardization is essential.

    • Conclusions:

    • Addressing uniform units, cost-effectiveness, and community commitment is vital for successful allergen standardization.
    • Collaboration among all stakeholders is necessary for advancing allergen immunotherapy.